Trace Neuroscience
Latest round
- Series A
Last raised
- Nov 2024
Total raised
- $101M
Investors
- 4
About Trace Neuroscience
Based in California, US, and founded in 2024, Trace Neuroscience, Inc. operates as a biopharmaceutical company that specializes in surgical imaging technology for people living with neurodegenerative diseases. In November 2024, Trace Neuroscience, Inc. As of November 2024, Eric Green is the CEO of the company. Trace Biosciences focuses on developing innovative imaging agents designed to enhance surgical procedures by providing real-time visualization of nerves. The company’s primary product, Nerve Trace, is engineered to highlight all nerves within the body after a single intravenous injection. This technology integrates seamlessly with existing clinical imaging systems and employs fluorescence to deliver immediate visual feedback, aiming to reduce the incidence of surgical nerve damage. By addressing the critical needs of surgeons and enhancing surgical outcomes, Trace Biosciences targets hospitals and surgical facilities globally, particularly in advanced healthcare markets such as the United States and Europe. Trace Biosciences generates revenue through direct sales of its flagship product, Nerve Trace, to healthcare providers and surgical institutions. The business model is structured around B2B transactions, where surgical hospitals and clinics purchase the imaging agents as essential tools for procedures that risk nerve damage. This will support the development of upcoming products intended to enhance surgical outcomes and expand into new markets such as Europe and Asia by 2025.
Who invested in Trace Neuroscience
4 investors across 1 round
See all investors in Trace Neuroscience
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Nov 12, 2024
Amount
$101M
Investors
Questions about Trace Neuroscience
Who invested in Trace Neuroscience?
Trace Neuroscience has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Trace Neuroscience raised?
Trace Neuroscience has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Trace Neuroscience last raise money?
Trace Neuroscience's most recent round on record is a Series A, in Nov 2024.
What does Trace Neuroscience do?
Based in California, US, and founded in 2024, Trace Neuroscience, Inc.
Where is Trace Neuroscience headquartered?
Trace Neuroscience is headquartered in South San Francisco, US.
Which VCs invest in companies like Trace Neuroscience?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Trace Neuroscience's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Trace Neuroscience? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.